{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:38:00Z","timestamp":1792805880274,"version":"4.5.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Feline idiopathic cystitis is a common, chronic-relapsing disorder of the lower urinary tract. In addition to environmental modification\/enrichment, long-term and safe treatment targeting specific pathophysiological changes may be of help. In this context, effective dietary interventions hold clinical promise. Palmitoyl-glucosamine (PGA) and hesperidin (HSP) are safe and authorized feed ingredients for animal nutrition under European regulations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The current study aimed to investigate whether a 3:1 mixture of micronized PGA and HSP could represent a novel mechanism-oriented approach to chronic cystitis management. A newly validated rat model of cyclophosphamide (CYP)-induced chronic cystitis was used (40\u2009mg\/kg, three intraperitoneal injections every 3rd day). Animals were randomized to orally receive either vehicle or PGA-HSP at a low (72\u2009+\u200924\u2009mg\/kg) or high (doubled) dose for 13\u2009days, starting 3\u2009days before the chronic CYP protocol, with mesna (2-mercaptoethane-sulfonate) being used as a reference drug.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Higher PGA-HSP dose was effective at relieving chronic visceral pain, as measured by mechanical allodynia test (von Frey test). The severity of cystitis was also significantly improved, as shown by the reduced sonographic thickening of the bladder wall, as well as the decrease in edema, bleeding and bladder to body weight ratio compared to the vehicle treated group. A significant decrease of MPO activity, MDA level and fibrosis at Masson\u2019s trichrome staining was also observed in animals administered PGA-HSP in comparison to vehicle treated ones. The CYP-induced increase in bladder mRNA expression of pro-inflammatory cytokines was also significantly counteracted by the study mixture. Moreover, CYP-induced bladder mast cell accumulation and releasability were significantly decreased by PGA-HSP (even at the low dose), as determined by metachromatic staining, chymase and tryptase immunostaining as well as enzyme-linked immunosorbent assay for histamine and 5-hydoxytriptamine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>PGA-HSP is able to block CYP-induced decrease of tight junction proteins, claudin-1 and occludin, thus preserving the urothelial bladder function. Finally, neuroinflammatory changes were investigated, showing that dietary supplementation with PGA-HSP prevented the activation of neurons and non-neuronal cells (i.e., microglia, astrocytes and mast cells) at the spinal level, and counteracted CYP-induced increase of spinal mRNA encoding for pro-inflammatory cytokines. Altogether, the present findings confirm the uroprotective and pain-relieving effect of PGA-HSP and pave the way to potential and relevant clinical applications of the study supplement in feline idiopathic cystitis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fvets.2023.1327102","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:40:01Z","timestamp":1704343201000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Uroprotective and pain-relieving effect of dietary supplementation with micronized palmitoyl-glucosamine and hesperidin in a chronic model of cyclophosphamide-induced cystitis"],"prefix":"10.3389","volume":"10","author":[{"given":"Enrico","family":"Gugliandolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca Antonio","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylenia","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio Filippo","family":"Peritore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Impellizzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Cordaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Siracusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Macr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Crupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1177\/1098612X19862887","article-title":"Recurrence rate and long-term course of cats with feline lower urinary tract disease","volume":"22","author":"Kaul","year":"2020","journal-title":"J Feline Med Surg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1177\/1098612X21990302","article-title":"Retrospective interview-based long-term follow-up study of cats diagnosed with idiopathic cystitis in 2003-2009","volume":"23","author":"Eggertsd\u00f3ttir","year":"2021","journal-title":"J Feline Med Surg"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cvsm.2015.02.007","article-title":"Feline idiopathic cystitis","volume":"45","author":"Forrester","year":"2015","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fnsys.2018.00013","article-title":"Inflammation and tissue remodeling in the bladder and urethra in feline interstitial cystitis","volume":"12","author":"Kullmann","year":"2018","journal-title":"Front Syst Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"F540","DOI":"10.1152\/ajprenal.2000.278.4.F540","article-title":"Urothelial pathophysiological changes in feline interstitial cystitis: a human model","volume":"278","author":"Lavelle","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s11255-015-1021-1","article-title":"Evaluation of oxidative stress status and antioxidant capacity in patients with painful bladder syndrome\/interstitial cystitis: preliminary results of a randomised study","volume":"47","author":"Ener","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/diagnostics12010075","article-title":"Urinary biomarkers in interstitial cystitis\/bladder pain syndrome and its impact on therapeutic outcome","volume":"12","author":"Lin","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4009308","DOI":"10.1155\/2021\/4009308","article-title":"Nrf 2 pathway ameliorates bladder dysfunction in cyclophosphamide-induced cystitis via suppression of oxidative stress","volume":"2021","author":"Ni","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3390\/antiox10071046","article-title":"Hidrox\u00ae and chronic cystitis: biochemical evaluation of inflammation, oxidative stress, and pain","volume":"10","author":"D\u2019Amico","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3389\/fnins.2018.00931","article-title":"Mechanisms underlying overactive bladder and interstitial cystitis\/painful bladder syndrome","volume":"12","author":"Grundy","year":"2018","journal-title":"Front Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/iju.13985","article-title":"Pathophysiology of interstitial cystitis","volume":"26","author":"Birder","year":"2019","journal-title":"Int J Urol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"17562872211022478","DOI":"10.1177\/17562872211022478","article-title":"Current standard of care in treatment of bladder pain syndrome\/interstitial cystitis","volume":"13","author":"Lopez","year":"2021","journal-title":"Ther Adv Urol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/14740338.2021.1921733","article-title":"Comparative safety review of current pharmacological treatments for interstitial cystitis\/bladder pain syndrome","volume":"20","author":"Chen","year":"2021","journal-title":"Expert Opin Drug Saf"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cvsm.2018.11.001","article-title":"Chronic lower urinary tract signs in cats: current understanding of pathophysiology and management","volume":"49","author":"Westropp","year":"2019","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/vms3.197","article-title":"The effect of a therapeutic urinary stress diet on the short-term recurrence of feline idiopathic cystitis","volume":"6","author":"Naarden","year":"2020","journal-title":"Vet Med Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3389\/fphar.2020.01305","article-title":"Characterization and validation of a chronic model of cyclophosphamide-induced interstitial cystitis\/bladder pain syndrome in rats","volume":"11","author":"Aug\u00e9","year":"2020","journal-title":"Front Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/ijms22031491","article-title":"N-palmitoyl-D-glucosamine, a natural monosaccharide-based glycolipid, inhibits TLR4 and prevents LPS-induced inflammation and neuropathic pain in mice","volume":"22","author":"Iannotta","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.3390\/vetsci7020078","article-title":"Palmitoylethanolamide and related ALIAmides: Prohomeostatic lipid compounds for animal health and wellbeing","volume":"7","author":"Gugliandolo","year":"2020","journal-title":"Vet Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"C145","DOI":"10.1007\/BF01972748","article-title":"A proposed autacoid mechanism controlling mastocyte behaviour","volume":"39","author":"Aloe","year":"1993","journal-title":"Agents Actions"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s12035-015-9253-8","article-title":"N-Palmitoylethanolamine and Neuroinflammation: a novel therapeutic strategy of resolution","volume":"52","author":"Skaper","year":"2015","journal-title":"Mol Neurobiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000542-200103000-00023","article-title":"Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder","volume":"94","author":"Farquhar-Smith","year":"2001","journal-title":"Anesthesiology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0304-3959(01)00419-5","article-title":"Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB (1) and CB (2)-like receptors","volume":"97","author":"Farquhar-Smith","year":"2002","journal-title":"Pain"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.juro.2014.11.083","article-title":"Protective effect of palmitoylethanolamide in a rat model of cystitis","volume":"193","author":"Pessina","year":"2015","journal-title":"J Urol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/ptr.7306","article-title":"Old dog, new tricks: Polydatin as a multitarget agent for current diseases","volume":"36","author":"Ye","year":"2022","journal-title":"Phytother Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"9828397","DOI":"10.1155\/2019\/9828397","article-title":"Micronized Palmitoylethanolamide-Polydatin reduces the painful symptomatology in patients with interstitial cystitis\/bladder pain syndrome","volume":"2019","author":"Cervigni","year":"2019","journal-title":"Biomed Res Int"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13075-019-2048-y","article-title":"Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain","volume":"21","author":"Cordaro","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/biom12081163","article-title":"N-Palmitoyl-D-glucosamine inhibits TLR-4\/NLRP3 and improves DNBS-induced Colon inflammation through a PPAR-\u03b1-dependent mechanism","volume":"12","author":"Palenca","year":"2022","journal-title":"Biomol Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2885.2006.00765_2.x","article-title":"G01 Glupamid: a novel nutraceutical approach to canine and feline osteoarthritis","volume":"29","author":"Miolo","year":"2006","journal-title":"J Vet Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2460\/ajvr.72.6.843","article-title":"Effects of oral administration of N-acetyl-d-glucosamine on plasma and urine concentrations of glycosaminoglycans in cats with idiopathic cystitis","volume":"72","author":"Panchaphanpong","year":"2011","journal-title":"Am J Vet Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jfms.2003.09.007","article-title":"Oral glucosamine and the management of feline idiopathic cystitis","volume":"6","author":"Gunn-Moore","year":"2004","journal-title":"J Feline Med Surg"},{"key":"ref31","first-page":"4410","article-title":"Treatment of refractory interstitial cystitis\/painful bladder syndrome with CystoProtek--an oral multi-agent natural supplement","volume":"15","author":"Theoharides","year":"2008","journal-title":"Can J Urol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e06709","DOI":"10.2903\/j.efsa.2021.6709","article-title":"Safety and efficacy of a feed additive consisting of a flavonoid-rich dried extract of Citrus \u00d7 aurantium L. fruit (bitter orange extract) for use in all animal species (FEFANA asbl)","volume":"19","author":"Bampidis","year":"2021","journal-title":"EFSA J"},{"key":"ref33","year":"2022"},{"key":"ref34","year":"2016"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00210-011-0668-0","article-title":"Effects of the hydroalcoholic extract of Phyllanthus niruri and its isolated compounds on cyclophosphamide-induced hemorrhagic cystitis in mouse","volume":"384","author":"Boeira","year":"2011","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.phrs.2018.05.013","article-title":"Adelmidrol + sodium hyaluronate in IC\/BPS or conditions associated to chronic urothelial inflammation. A translational study","volume":"134","author":"Ostardo","year":"2018","journal-title":"Pharmacol Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"35672","DOI":"10.1038\/srep35672","article-title":"Specific inhibition of ICAM-1 effectively reduces bladder inflammation in a rat model of severe non-bacterial cystitis","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1038\/s41598-021-83170-8","article-title":"Protective effect of snail secretion filtrate against ethanol-induced gastric ulcer in mice","volume":"11","author":"Gugliandolo","year":"2021","journal-title":"Sci Rep"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/mol.116.105668","article-title":"Adelmidrol, a Palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease","volume":"90","author":"Cordaro","year":"2016","journal-title":"Mol Pharmacol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.phrs.2017.12.022","article-title":"Anti-inflammatory effect of ATB-352, a H2S-releasing ketoprofen derivative, on lipopolysaccharide-induced periodontitis in rats","volume":"132","author":"Gugliandolo","year":"2018","journal-title":"Pharmacol Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12974-020-1704-0","article-title":"BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis","volume":"17","author":"Ding","year":"2020","journal-title":"J Neuroinflammation"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0022-5347(17)44929-9","article-title":"Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy","volume":"136","author":"Gray","year":"1986","journal-title":"J Urol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0090-4295(01)01129-3","article-title":"Mast cell involvement in interstitial cystitis: a review of human and experimental evidence","volume":"57","author":"Theoharides","year":"2001","journal-title":"Urology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"990178","DOI":"10.3389\/fphys.2022.990178","article-title":"Activation of uroepithelial 5-HT4R inhibits mechanosensory activity of murine bladder afferent nerves","volume":"13","author":"Lu","year":"2022","journal-title":"Front Physiol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1791222","DOI":"10.1155\/2021\/1791222","article-title":"Notch 1 signaling contributes to mechanical allodynia associated with cyclophosphamide-induced cystitis by promoting microglia activation and Neuroinflammation","volume":"2021","author":"Chen","year":"2021","journal-title":"Mediat Inflamm"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.3390\/ijms24032821","article-title":"Why are some people with lower urinary tract symptoms (LUTS) depressed? New evidence that peripheral inflammation in the bladder causes central inflammation and mood disorders","volume":"24","author":"Hughes","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"665066","DOI":"10.3389\/fncel.2021.665066","article-title":"Involvement of mast cells in the pathophysiology of pain","volume":"15","author":"Mai","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1939-1676.2011.0732.x","article-title":"Idiopathic cystitis in domestic cats--beyond the lower urinary tract","volume":"25","author":"Buffington","year":"2011","journal-title":"J Vet Intern Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"900847","DOI":"10.3389\/fvets.2022.900847","article-title":"Prevalence, risk factors, pathophysiology, potential biomarkers and Management of Feline Idiopathic Cystitis: an update review","volume":"9","author":"He","year":"2022","journal-title":"Front Vet Sci"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"E1827","DOI":"10.3390\/ani10101827","article-title":"Dietary supplementation with Palmitoyl-glucosamine co-micronized with curcumin relieves osteoarthritis pain and benefits joint mobility","volume":"10","author":"Gugliandolo","year":"2020","journal-title":"Animals (Basel)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"174480691667447","DOI":"10.1177\/1744806916674479","article-title":"Spinal astrocytic activation contributes to mechanical allodynia in a rat model of cyclophosphamide-induced cystitis","volume":"12","author":"Liu","year":"2016","journal-title":"Mol Pain"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/nau.24005","article-title":"Neuregulin-1-ErbB signaling promotes microglia activation contributing to mechanical allodynia of cyclophosphamide-induced cystitis","volume":"38","author":"Chen","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.09.018","article-title":"A focus on mast cells and pain","volume":"264","author":"H\u00e9ron","year":"2013","journal-title":"J Neuroimmunol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fncel.2019.00110","article-title":"Mast cell neural interactions in health and disease","volume":"13","author":"Mittal","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/ejp.1086","article-title":"Evidence for the modulation of nociception in mice by central mast cells","volume":"21","author":"Kissel","year":"2017","journal-title":"Eur J Pain"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0166-2236(96)10058-8","article-title":"Nerve growth factor: from neurotrophin to neurokine","volume":"19","author":"Levi-Montalcini","year":"1996","journal-title":"Trends Neurosci"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.pain.2014.05.029","article-title":"Multidisciplinary approach to the study of chronic pelvic pain (MAPP) research network. Inflammation and inflammatory control in interstitial cystitis\/bladder pain syndrome: associations with painful symptoms","volume":"155","author":"Schrepf","year":"2014","journal-title":"Pain"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"F90","DOI":"10.1152\/ajprenal.00017.2019","article-title":"Cystitis-induced bladder pain is toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP research network animal study","volume":"317","author":"Cui","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","article-title":"Neuroinflammation pathways: a general review","volume":"127","author":"Shabab","year":"2017","journal-title":"Int J Neurosci"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"F460","DOI":"10.1152\/ajprenal.00100.2018","article-title":"Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitis","volume":"315","author":"de Oliveira","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1556\/2060.2020.00003","article-title":"The protective effect of hesperidin against renal ischemia-reperfusion injury involves the TLR-4\/NF-\u03baB\/iNOS pathway in rats","volume":"107","author":"Meng","year":"2020","journal-title":"Physiol Int"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4111\/icu.2020.61.1.75","article-title":"High-definition ultrasound characterization of acute cyclophosphamide-induced cystitis in the mouse","volume":"61","author":"Lee","year":"2020","journal-title":"Investig Clin Urol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13014-020-01684-3","article-title":"A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in rats","volume":"15","author":"Spinelli","year":"2020","journal-title":"Radiat Oncol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11255-019-02128-y","article-title":"Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice","volume":"51","author":"Barut","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0022-5347(05)67873-1","article-title":"Recruitment, distribution and phenotypes of mast cells in interstitial cystitis","volume":"163","author":"Peeker","year":"2000","journal-title":"J Urol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jcpa.2021.03.006","article-title":"Feline idiopathic cystitis: pathogenesis, histopathology and comparative potential","volume":"185","author":"Jones","year":"2021","journal-title":"J Comp Pathol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/his.13235","article-title":"Histopathological characteristics of interstitial cystitis\/bladder pain syndrome without Hunner lesion","volume":"71","author":"Kim","year":"2017","journal-title":"Histopathology"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urology.2006.08.1109","article-title":"The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis","volume":"69","author":"Sant","year":"2007","journal-title":"Urology"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"e0168772","DOI":"10.1371\/journal.pone.0168772","article-title":"Evidence for the role of mast cells in cystitis-associated lower urinary tract dysfunction: a multidisciplinary approach to the study of chronic pelvic pain research network animal model study","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12325-015-0240-2","article-title":"Regulatory effects of 5-Hydroxytryptamine receptors on voiding function","volume":"32","author":"Matsumoto-Miyai","year":"2015","journal-title":"Adv Ther"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12894-019-0548-3","article-title":"Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome\/interstitial cystitis \u2013 significance in the responsiveness to antihistamine treatment and disease symptoms","volume":"19","author":"Shan","year":"2019","journal-title":"BMC Urol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"F298","DOI":"10.1152\/ajprenal.00435.2019","article-title":"Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H1 receptor and TRPV1","volume":"318","author":"Grundy","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.3390\/ijms24043982","article-title":"Involvement of mast-cell-Tryptase-and protease-activated receptor 2-mediated signaling and urothelial barrier dysfunction with reduced Uroplakin II expression in bladder hyperactivity induced by chronic bladder ischemia in the rat","volume":"24","author":"Akaihata","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1152\/physrev.00030.2012","article-title":"Urothelial signaling","volume":"93","author":"Birder","year":"2013","journal-title":"Physiol Rev"},{"key":"ref75","first-page":"51","article-title":"Evaluation of toxicity of a chronic alternate day metronomic cyclophosphamide chemotherapy protocol in dogs with naturally occurring cancer","volume":"58","author":"Matsuyama","year":"2017","journal-title":"Can Vet J"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/antiox12020280","article-title":"Neuroprotective potentials of flavonoids: experimental studies and mechanisms of action","volume":"12","author":"Bellavite","year":"2023","journal-title":"Antioxidants (Basel)"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2023.1327102\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:40:05Z","timestamp":1704343205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2023.1327102\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":76,"alternative-id":["10.3389\/fvets.2023.1327102"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2023.1327102","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"article-number":"1327102"}}